Ipamorelin (link:https://www.bloomtechz.com/synthetic-chemical/peptide/lpamorelin-powder-cas-170851-70-4.html) is a biologically active polypeptide, a growth hormone releasing peptide (GHRP) synthesized in the body. The structure of Ipamorelin is similar to that of GHRP-2 and GHRP-6, but it is relatively shorter and consists of five amino acids. Soluble in water, but low solubility in organic solvents. It is a polar compound with many hydrophilic groups such as amino and carboxyl. These hydrophilic groups enable good water solubility. It is a peptide hormone that can be used to treat adult growth hormone deficiency. Its synthesis methods include solid-phase synthesis, liquid-phase synthesis, chemical-biological joint synthesis, etc. These methods are described in detail below.
1. Solid-phase synthesis method:
Solid-phase synthesis is one of the commonly used methods to prepare Ipamorelin, which has the advantages of high efficiency, economy and high purity. First use Fmoc or Boc to protect the amino group in the amino acid, then use the amino acid-N-carboxylic acid as the starting compound, and connect other amino acids in turn to gradually synthesize a complete polypeptide chain. In each step, unconventional reaction conditions are imposed, such as carbonyl dimethylacetone (DCC) and N,N-dimethylamine (DMAP), and strong acids such as trifluoroacetic acid are used to remove the protecting groups. Finally, the N-terminal protecting group is removed by hydrolysis to obtain the Ipamorelin polypeptide.
Specific steps are as follows:
1.1. Determine the protecting group and amino acid sequence:
In solid phase synthesis, every amino acid needs to be protected. Protecting groups such as t-Butyloxycarbonyl (t-Boc) or Fmoc are usually used. The sequence of amino acids needs to be determined and is usually synthesized from the C-terminus to the N-terminus. For Ipamorelin, its amino acid sequence is His-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2, and protection is carried out according to this sequence.
1.2. Preparation of synthetic carrier:
Synthetic carrier is the material used to carry amino acid and react in solid phase synthesis. Materials such as polystyrene are usually used as a carrier to fix it in the reactor. The hydroxyl or amine groups of the carrier need to be surface-activated first so that they can react with the first amino acid. This is usually achieved by subjecting the support to hydrochloric acid or reacting with nitrous acid.
1.3. Quality determination:
Before proceeding with the synthesis, the carrier needs to be mass determined. Spectroscopic methods such as infrared spectroscopy (IR) and nuclear magnetic resonance (NMR) are often used to confirm the quality and activity of the carrier.
1.4. Link the first amino acid:
React the first protected amino acid with the activated carrier surface. This usually requires the addition of an activating reagent such as dimethylaminopropanol (DMA) or tetrahydrofuran alcohol (THF). Washing and drying are required after the reaction to ensure the non-polluting nature of the next reaction.
1.5. Iteratively repeat the amino acid addition and deprotection steps:
According to the amino acid sequence, the protected amino acids are sequentially added, and the activation and conjugation reactions are carried out. Then use an appropriate deprotection reagent, such as trifluoroacetic acid (TFA) or pyrrolidine-1-carboxylic acid (Piperidine), etc., to remove the protecting group in the amino acid. This step requires strict control of reaction time and temperature to avoid side reactions.
1.6. Determination of Purity and Quality:
After the synthesis is completed, the reaction product needs to be tested for quality and purity. This can be achieved by methods such as high performance liquid chromatography (HPLC) and mass spectrometry (MS). In addition, nuclear magnetic resonance spectroscopy (NMR) can be used to confirm the structure and purity of the product.
1.7. Separation and purification:
Separation and purification is the process of separating the reaction product from the carrier and waste. Separation is usually carried out by methods such as counter flow analysis or gel filtration. Then wash, dry and freeze-dry to obtain pure Ipamorelin.
In conclusion, solid-phase synthesis is one of the main methods for synthesizing Ipamorelin. The steps include selecting protective groups and amino acid sequences, synthesizing carriers, measuring mass, linking the first amino acid, repeatedly adding amino acids and deprotection steps, determining purity and quality, and separating and purifying. This method has the advantages of high efficiency, economy, and high purity, and is suitable for large-scale synthesis.
2. Liquid phase synthesis method:
Liquid phase synthesis is another method used to synthesize Ipamorelin. In solution-phase synthesis, the starting material is first attached to a hydrophilic polypeptide matrix, and amino acids are added using activators such as HATU or EDC. Then through the reaction to gradually build the target peptide. During the reaction, appropriate solution and temperature can be used to control the reaction rate. Finally, the protective group is removed by acidic or basic conditions to obtain Ipamorelin. Compared with solid-phase synthesis, liquid-phase synthesis can quickly obtain high-purity products, so it is also a common method for preparing Ipamorelin. Specific steps are as follows:
2.1. Determine the protecting group and amino acid sequence:
In solution phase synthesis, every amino acid needs to be protected. Protecting groups such as t-Butyloxycarbonyl (t-Boc) or Fmoc are usually used. The sequence of amino acids needs to be determined and is usually synthesized from the C-terminus to the N-terminus. For Ipamorelin, its amino acid sequence is His-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2, and protection is carried out according to this sequence.
2.2. Synthetic starting materials:
Synthetic starting material is one of the key steps in liquid phase synthesis, it serves as the first component of the amino acid chain and is used to link subsequent amino acids. Typically, the starting material for the synthesis is an alkylpeptide containing a protecting group. In the liquid phase synthesis of Ipamorelin, the commonly used synthetic starting material is t-Boc-His(Boc)-OH.
2.3. Amino acid coupling reaction:
In solution-phase synthesis, each amino acid needs to be linked to the previous amino acid through a coupling reaction. Commonly used coupling agents are dimethyltetrahydrofuran (DMF) and dimethylthiourea (DMSO). The ratio of amino acid and coupling agent and the reaction conditions need to be adjusted according to the specific situation to ensure the reaction effect and product quality.
2.4. Removal of protecting groups:
After completing the amino acid coupling reaction, the protecting group in the amino acid needs to be removed. This is also a critical step in liquid-phase synthesis. Commonly used deprotecting agents include trifluoroacetic acid (TFA), n-butanethiol (n-ButSH), and pyridine (Py), etc. It is necessary to select a suitable deprotecting agent according to the reaction conditions and product types, and strictly control the temperature and time of deprotection, and ensure the pH value in the reaction.
2.5. Determination of Purity and Quality:
After the synthesis is completed, the reaction product needs to be tested for quality and purity. Methods such as high performance liquid chromatography (HPLC) and mass spectrometry (MS) can be used to confirm the structure and purity of the product.
2.6. Separation and purification:
Separation and purification is the process of separating reaction products from waste. Separation is usually carried out by methods such as counter flow analysis or gel filtration. Then wash, dry and freeze-dry to obtain pure Ipamorelin.
In conclusion, liquid phase synthesis is a common method for preparing Ipamorelin. The steps include determining the protective group and amino acid sequence, synthesizing starting materials, amino acid coupling reaction, removing the protecting group, determining the purity and quality, and separating and purifying. This method has the advantage of rapidly obtaining high-purity products and is suitable for small-scale or medium-scale syntheses.
3. Chemical-biological joint synthesis method:
The combined chemical-biological synthesis method is one of the emerging methods for preparing Ipamorelin in recent years. This method combines the advantages of solid-phase synthesis and synthetic biology methods, mainly to synthesize polypeptide chains, and then uses synthetic biology methods to complete the rest. First, some peptides are synthesized by solid-phase synthesis or liquid-phase synthesis, and then the remaining peptides are synthesized by synthetic biology methods. This method has the advantages of high efficiency, controllability, flexibility, etc., and can change the biological activity of Ipamorelin through appropriate modification.
In summary, the above are three methods for preparing Ipamorelin, which are solid-phase synthesis, liquid-phase synthesis and chemical-biological joint synthesis. These methods have their own advantages and disadvantages. For example, the solid-phase synthesis method has high synthesis efficiency and good reproducibility; the liquid-phase synthesis method has the characteristics of simple operation and fast synthesis speed; the chemical-biological combined synthesis method combines the advantages of the two methods. together to finally obtain the target compound. Choosing the most suitable method for engineering needs in production helps to improve the production efficiency and quality of Ipamorelin.